Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth E Palmer

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Pharmaceutics|April 19, 2019
Design of Poly(lactic-<i>co</i>-glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV ProphylaxisHaitao Yang, Jing Li, Sravan Kumar Patel, et al.
Bioconjugate Chemistry|September 21, 2006
Chemical conjugate TMV-peptide bivalent fusion vaccines improve cellular immunity and tumor protectionAlison A McCormick, Tina A Corbo, Sherri Wykoff-Clary, et al.
Microbiology Spectrum|September 8, 2021
Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral LectinHenry W Nabeta, Joseph C Kouokam, Amanda B Lasnik, et al.
Experimental and Molecular Pathology|May 21, 2009
Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancerKenneth E Palmer, A Bennett Jenson, J Calvin Kouokam, et al.
International Journal of Nanomedicine|February 24, 2021
In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 InfectionFarnaz Minooei, Joel R Fried, Joshua L Fuqua, et al.
Virology Journal|February 9, 2011
The porcine circovirus type 1 capsid gene promoter improves antigen expression and immunogenicity in a HIV-1 plasmid vaccineFiona L Tanzer, Enid G Shephard, Kenneth E Palmer, et al.
Plant Biotechnology Journal|March 7, 2018
Characterization of the hypersensitive response-like cell death phenomenon induced by targeting antiviral lectin griffithsin to the secretory pathwayBo Min Kim, Hester Catharina Therese Lotter-Stark, Edward P Rybicki, et al.
Frontiers in Cellular and Infection Microbiology|November 4, 2022
Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasisHenry W Nabeta, Amanda B Lasnik, Joshua L Fuqua, et al.
Journal of Biotechnology|June 20, 2020
Stability of plasmid and viral banks supporting the cGMP manufacture of Q-Griffithsin from a TMV-based viral vectorJulia M Corman, Krystal T Hamorsky, John W Shepherd, et al.
The Journal of General Virology|May 9, 2007
Identification of long intergenic region sequences involved in maize streak virus replicationJanet A Willment, Darrin P Martin, Kenneth E Palmer, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Pharmaceutics|April 19, 2019
Design of Poly(lactic-<i>co</i>-glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV ProphylaxisHaitao Yang, Jing Li, Sravan Kumar Patel, et al.
Bioconjugate Chemistry|September 21, 2006
Chemical conjugate TMV-peptide bivalent fusion vaccines improve cellular immunity and tumor protectionAlison A McCormick, Tina A Corbo, Sherri Wykoff-Clary, et al.
Microbiology Spectrum|September 8, 2021
Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral LectinHenry W Nabeta, Joseph C Kouokam, Amanda B Lasnik, et al.
Experimental and Molecular Pathology|May 21, 2009
Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancerKenneth E Palmer, A Bennett Jenson, J Calvin Kouokam, et al.
International Journal of Nanomedicine|February 24, 2021
In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 InfectionFarnaz Minooei, Joel R Fried, Joshua L Fuqua, et al.
Virology Journal|February 9, 2011
The porcine circovirus type 1 capsid gene promoter improves antigen expression and immunogenicity in a HIV-1 plasmid vaccineFiona L Tanzer, Enid G Shephard, Kenneth E Palmer, et al.
Plant Biotechnology Journal|March 7, 2018
Characterization of the hypersensitive response-like cell death phenomenon induced by targeting antiviral lectin griffithsin to the secretory pathwayBo Min Kim, Hester Catharina Therese Lotter-Stark, Edward P Rybicki, et al.
Frontiers in Cellular and Infection Microbiology|November 4, 2022
Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasisHenry W Nabeta, Amanda B Lasnik, Joshua L Fuqua, et al.
Journal of Biotechnology|June 20, 2020
Stability of plasmid and viral banks supporting the cGMP manufacture of Q-Griffithsin from a TMV-based viral vectorJulia M Corman, Krystal T Hamorsky, John W Shepherd, et al.
The Journal of General Virology|May 9, 2007
Identification of long intergenic region sequences involved in maize streak virus replicationJanet A Willment, Darrin P Martin, Kenneth E Palmer, et al.
Pageof 7